 |
|
Neuroprotective Effects of Cognitive Enhancement Therapy Against Gray Matter Loss in Early SchizophreniaResults From a 2-Year Randomized Controlled Trial
Shaun M. Eack, PhD;
Gerard E. Hogarty, MSW ;
Raymond Y. Cho, MD;
Konasale M. R. Prasad, MD;
Deborah P. Greenwald, PhD;
Susan S. Hogarty, MSN;
Matcheri S. Keshavan, MD
Arch Gen Psychiatry. 2010;67(7):(doi:10.1001/archgenpsychiatry.2010.63).
Context Cognitive rehabilitation has shown efficacy in improving cognition in patients with schizophrenia but the underlying neurobiologic changes that occur during these treatments and support cognitive improvement are not well known.
Objective To examine differential changes in brain morphology in early course schizophrenia during cognitive rehabilitation vs supportive therapy.
Design Randomized controlled trial.
Setting An outpatient research clinic at a university-based medical center that provides comprehensive care services for patients with severe mental illness.
Patients A total of 53 symptomatically stable but cognitively disabled outpatients in the early course of schizophrenia or schizoaffective disorder.
Interventions A 2-year trial with annual structural magnetic resonance imaging and cognitive assessments. Cognitive enhancement therapy is an integrated approach to the remediation of cognitive impairment in schizophrenia that uses computer-assisted neurocognitive training and group-based social-cognitive exercises. Enriched supportive therapy is an illness management approach that provides psychoeducation and teaches applied coping strategies.
Main Outcome Measures Broad areas of frontal and temporal gray matter change were analyzed with longitudinal, voxel-based morphometry methods using mixed-effects models followed by volumetric analyses of regions that demonstrated significant differential changes between treatment groups.
Results Patients who received cognitive enhancement therapy demonstrated significantly greater preservation of gray matter volume over 2 years in the left hippocampus, parahippocampal gyrus, and fusiform gyrus, and significantly greater gray matter increases in the left amygdala (all corrected P < .04) compared with those who received enriched supportive therapy. Less gray matter loss in the left parahippocampal and fusiform gyrus and greater gray matter increases in the left amygdala were significantly related to improved cognition and mediated the beneficial cognitive effects of cognitive enhancement therapy.
Conclusion Cognitive enhancement therapy may offer neurobiologic protective and enhancing effects in early schizophrenia that are associated with improved long-term cognitive outcomes.
Trial Registration clinicaltrials.gov Identifier: NCT00167362
Author Affiliations: Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine (Drs Eack, Cho, Prasad, Greenwald, and Keshavan, Mr G. E. Hogarty, and Ms S. S. Hogarty), School of Social Work, University of Pittsburgh (Dr Eack); and Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts (Dr Keshavan).
Died April 7, 2006.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?
Keefe et al.
Schizophr Bull 2011;0:sbr153v1-sbr153.
ABSTRACT
| FULL TEXT
Compensatory Cognitive Training for Psychosis: Who Benefits? Who Stays in Treatment?
Twamley et al.
Schizophr Bull 2011;37:S55-S62.
ABSTRACT
| FULL TEXT
Harnessing neuroplasticity for clinical applications
Cramer et al.
Brain 2011;134:1591-1609.
ABSTRACT
| FULL TEXT
Divergent Trajectories of Physical, Cognitive, and Psychosocial Aging in Schizophrenia
Jeste et al.
Schizophr Bull 2011;37:451-455.
ABSTRACT
| FULL TEXT
Brain Exercise for Patients with Schizophrenia
JWatch Psychiatry 2010;2010:1-1.
FULL TEXT
|
